Viewing Study NCT02744092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-06-06 @ 6:05 PM
Study NCT ID: NCT02744092
Status: COMPLETED
Last Update Posted: 2023-10-03
First Post: 2016-04-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Sponsor: Alliance Foundation Trials, LLC.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Venous Thromboembolism View
None Deep Vein Thrombosis (DVT) View
None Pulmonary Embolism (PE) View
None Blood Clot View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rivaroxaban (Xarelto) View
None Apixaban (Eliquis) View
None Edoxaban (Savaysa) View
None Dabigatran (Pradaxa) View
None Warfarin (Coumadin) View
None Low molecular weight heparin (LMWH) View